Stanford University
Showing 441-460 of 599 Results
-
Terry Moe
William Bennett Munro Professor of Political Science and Senior Fellow at the Hoover Institution, Emeritus
Current Research and Scholarly InterestsThe presidency, American political institutions, education politics.
-
W. E. Moerner
Harry S. Mosher Professor and Professor, by courtesy, of Applied Physics
Current Research and Scholarly InterestsLaser spectroscopy and microscopy of single molecules to probe biological systems, one biomolecule at a time. Primary thrusts: fluorescence microscopy far beyond the optical diffraction limit (PALM/STORM/STED), methods for 3D optical microscopy in cells, and trapping of single biomolecules in solution for extended study. We explore protein localization patterns in bacteria, structures of amyloid aggregates in cells, signaling proteins in the primary cilium, and dynamics of DNA and RNA.
-
Ariam Mogos
Lecturer
BioAriam Mogos leads emerging technology initiatives at Stanford's Hasso Plattner Institute of Design (d.school), where she helps students and educators work with emerging technologies like AI and blockchain, and shapes conversations around the tech’s ethical implications on humans and nature. Her design work and research also investigates the ways that technology can foster playful learning experiences that bridge communities and cultures.
-
Maha Abdalla Mohamed, MD, FACP, FAST
Clinical Associate Professor, Medicine - Nephrology
BioDr. Mohamed is a board-certified, fellowship-trained nephrologist with the Kidney and Pancreas Transplant Program at Stanford Healthcare. She is a clinical associate professor in the Department of Medicine, Division of Nephrology.
Dr. Mohamed specializes in kidney and pancreas transplant outcomes and kidney transplant health equity. Conditions she treats include allografts rejection, recipient BK virus and CMV infection, and post-transplant lymphoproliferative disorder management. Dr. Mohamed is known for her personalized and comprehensive approach to patient care. She takes the time to understand her patients’ unique health needs and creates tailored care plans that fit their lifestyles.
Dr. Mohamed’s research interests include examining new approaches to improving kidney transplant long-term outcome including kidney transplant rejection and infection. She also seeks to develop better screening and monitoring guidance to help reduce post-transplant BK virus and CMV infection.
Dr. Mohamed’s published work can be found in peer-reviewed journals such as Clinical Transplantation, Transplant Infectious Disease and Transplantation. She has presented to her peers at international, national, and regional meetings, including at the American Transplant Congress and the American Society of Nephrology. She has also been invited to speak multiple times at King Faisal Hospital in Rwanda as well as in Kingdom of Saudi Arabia on topics like post-transplant lymphoproliferative disorder, update in kidney transplant rejection, and update in living-donor kidney transplantation.
Dr. Mohamed is a faculty fellow of Stanford Center for Innovation in Global Health, fellow of the American Society of Transplantation, a board of managers member of the AST Transplant Nephrology Fellowship Training Accreditation Program, member of the International Society of Nephrology and the American Society of Nephrology. -
Anita Tanniru Mohan MBBS PhD MBA
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioAnita Mohan MBBS PhD MBA is a Clinical Assistant Professor in the Division of Plastic and Reconstructive Surgery. Dr Mohan graduated medical school from Imperial College London together with a bachelors with honors in Management (BSc). After completing core surgery residency training in London in the United Kingdom, she completed a clinical fellowship in plastic surgery, hand surgery and burns in Cape Town, South Africa. This was followed by plastic surgery training in Cambridge, United Kingdom. During her plastic surgery training program, Dr Mohan was awarded the Royal College of Surgeons (England) Blond McIndoe research scholarship which she used to pursue a post-doctoral research fellowship at the Mayo Clinic, Rochester Minnesota. In this time Dr Mohan completed her PhD from the University of Cambridge (U.K.) on the study of perforator anatomy and physiology of the microcirculation in breast reconstruction, for which she received the Royal College of Surgeons of England Aris and Gale Lectureship. Dr Mohan also worked in the lab at Mayo Clinic in the study of nerve regeneration in facial allotransplantation. Dr Mohan then went on to complete an integrated plastic surgery residency at the Mayo Clinic, Rochester Minnesota. Dr Mohan also completed her Masters in Business Administration (MBA) from the University of Minnesota during her residency training. Dr Mohan completed advanced training in reconstructive microsurgery at Stanford University and studied medical innovation in the Stanford Biodesign program.
Dr Mohan has a joint appointment at the Veteran’s Affairs Hospital in Palo Alto and Stanford University campus. Dr Mohan’s specializes in general reconstructive surgery, microsurgery and super-microsurgery techniques. Dr Mohan currently performs a broad scope of plastic surgery procedures, gender affirming top surgery with nipple neurotization, breast and abdominal procedures following massive weight loss, abdominal wall reconstruction, microsurgery reconstruction following cancer and trauma, lymphedema/lipedema and skin cancer surgery.
Dr Mohan’s research interests include the study of microcirculation and lymphedema research, clinical outcomes projects and simulation training. -
Minal Moharir
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioI was born, raised, and trained in Nashik, India where I completed my formal Medical Education before moving to New York City where I completed my residency in Internal Medicine at New York Downtown Hospital in New York, NY. My interests are in preventative medicne, health and wellness, occupational and environmental safety. In Stanford's Occupational Health Department, I practice clinical occupational medicine while working toward identifying health and safety issues within our enviroment to prevent further injury and illness to our employees.
-
David G. Mohler, MD
Clinical Professor, Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Mohler is involved in gene expression in sarcomas, and innovative anatomy-preserving surgical management of low grade chondrosarcomas.
-
Parviz Moin
Franklin P. and Caroline M. Johnson Professor in the School of Engineering
BioMoin is the founding director of the Center for Turbulence Research. Established in 1987 as a research consortium between NASA and Stanford, Center for Turbulence Research is devoted to fundamental studies of turbulent flows. Center of Turbulence Research is widely recognized as the international focal point for turbulence research, attracting diverse groups of researchers from engineering, mathematics and physics. He was the founding director of the Institute for Computational and Mathematical Engineering at Stanford.
Professor Moin pioneered the use of direct and Large Eddy Simulation techniques for the study of turbulence physics, control and modelling concepts and has written widely on the structure of turbulent shear flows. His current interests include: Computational physics, Physics and control of turbulent boundary layers, hypersonic flows, propulsion, flow control, large eddy simulation for aerospace applications and aircraft icing. -
James M. Mok, MD
Clinical Associate Professor, Orthopaedic Surgery
BioDr. Mok is a board-certified, fellowship-trained spine surgeon with the Stanford Medicine Spine Center in Redwood City. He is also a clinical associate professor of medicine in the Department of Orthopaedic Surgery.
Dr. Mok diagnoses and treats a wide range of degenerative spine conditions, including disc herniations, spinal stenosis, myelopathy, and spondylolisthesis, as well as patients who have had previous spine surgery. He specializes in minimally invasive surgical techniques and strives to perform the least invasive procedures with the highest chances of success. His surgical specialties include minimally invasive microdiscectomy and laminectomy, minimally invasive spinal fusion, and artificial disc replacement.
Prior to Stanford, Dr. Mok worked as an orthopaedic spine surgeon with the NorthShore Orthopaedic and Spine Institute, the only dedicated orthopedic specialty hospital in the Chicago region. He was previously Associate Professor of Orthopaedic Surgery and Rehabilitation Medicine at the University of Chicago.
Dr. Mok served on active duty in the United States Army Medical Corps with the rank of Major. His military experience included deployment to the Iraq theater as an orthopaedic surgeon and spine surgery consultant.
Dr. Mok has published work in many leading journals in his field, including The Spine Journal, Spine, and Journal of Bone and Joint Surgery. He has presented to his peers at international, national, and regional meetings, including annual meetings of the North American Spine Society, the Society for Minimally Invasive Spine Surgery, and the American Association of Orthopaedic Surgeons.
Dr. Mok is a member of the American Academy of Orthopaedic Surgeons, the American Orthopaedic Association, the North American Spine Society, the Scoliosis Research Society, and the Society for Minimally Invasive Spine Surgery. -
Pedram Mokrian
Lecturer
Instructor, Stanford Center for Professional DevelopmentBioPedram Mokrian is Adjunct Professor at Stanford University and a lecturer at the Haas School of business at UC Berkeley where he teaches and advises entrepreneurs and global 1000 companies alike on entrepreneurship, business model disruption, and technology innovation strategy. He was previously a Principal at Mayfield, one of Silicon Valley’s most storied venture capital firms, where he was part of the investment team with over $3.5B assets under management. Mokrian is a founding Partner of the Ratio Academy, New Line Ventures. He also serves as a mentor or advisor to a number of start-ups, innovation incubators, including Global Innovation Catalyst, the Texas Medical Center Innovation Center, Innovation Labs, MISO, and Moog, and serves on the advisory board of Phillips66.
-
J. Moldowan
Professor (Research) of Geological and Environmental Sciences, Emeritus
Current Research and Scholarly InterestsOrganic geochemistry; study of molecular fossils (biomarkers) and their use in petroleum system analysis, reservoir characterization, environmental monitoring, molecular paleontology, global change, petroleum biodegradation in reservoir. Studies of thermal cracking of petroleum by deep burial or catalytic alteration in deep source rocks and reservoirs by using diamondoids. Applications to unconventional petroleun exploration and development.
-
Matteo Amitaba Mole'
Assistant Professor of Obstetrics and Gynecology (Reproductive & Stem Cell Biology)
Current Research and Scholarly InterestsThe research focus of our laboratory is centered on investigating the complex process of human embryo implantation. Due to the limited availability of suitable model systems and inability to directly observe this process in vivo, this has been traditionally referred to as the enigmatic stage of human embryonic development.
The successful implantation of an embryo is crucial for the establishment of a healthy pregnancy. During the transition between the first and second week of gestation, the human embryo must securely implant into the maternal uterus, initiating development of the placenta to receive necessary nutrients and oxygen for its growth until birth.
However, the process of implantation in humans is highly susceptible to failure, with a significant percentage of embryos unable to develop beyond this stage leading to early miscarriages. This clinically observed "implantation barrier" often requires patients to undergo numerous cycles of IVF treatment, with no guarantee of a successful pregnancy outcome.
The primary objective is to increase the understanding of maternal-embryo interactions initiated at implantation, with the goal of developing clinical interventions to address the high incidence of implantation failures underlying pre-clinical miscarriages.
